A Study to Test Different Doses of BI 456906 in Patients With Obesity
Status:
Completed
Trial end date:
2020-04-30
Target enrollment:
Participant gender:
Summary
Main objective is to investigate the tolerability of different titration schemes of BI 456906
in otherwise healthy patients with obesity/overweight, and to determine a titration scheme
for future studies.